देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
KETAMINE
Zoetis Ireland Limited
QN01AX03
KETAMINE
100 Mg/Ml
Solution for Injection
VPO: Veterinary Practitioner Only as defined in relevant national legislation
Canine, Equine, Feline
ketamine
Anaesthetic/Analgesic
Authorised
2015-03-20
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Ketavet 100 mg/ml Solution for injection for dogs, cats and horses 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear, colourless solution, free from visible evidence of contamination. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs, cats and horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The product may be used to induce anaesthesia: a) in conjunction with butorphanol and medetomidine in the dog and cat, b) in conjunction with xylazine in the dog, cat and horse, c) in conjunction with detomidine in the horse, d) in conjunction with romifidine in the horse. Based on the benefit/risk assessment performed by the veterinarian the product may be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required in the domestic cat. 4.3 CONTRAINDICATIONS Do not use in animals with pre-existing hepatic or renal pathology. Do not use in animals in shock or with apparent high blood pressure or glaucoma. Do not reverse ketamine combinations in dogs with atipamezole. Do not use ketamine as a sole agent in dogs or horses. Do not use in cases of known hypersensitivity to the active substance or any of the excipients. Each ml contains: ACTIVE SUBSTANCE: Ketamine: 100 mg (Equivalent to ketamine hydrochloride) 115.36 mg EXCIPIENT(S): Benzethonium chloride: 0.10 mg H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ पूरा दस्तावेज़ पढ़ें